Digital Therapeutics Market - By Sales Channel (B2C, B2B) By Application (Preventive Applications, Treatment/Care-related Applications) By Region (North America, Europe, APAC, Rest of the World (RoW) - Industry Analysis, Opportunity and Forecast 2020 To 2027
Published Date: May 2021
No. of Pages: 193
Status: Published
Report Code: ARI100817
The increasing smartphone and internet usage among the people is one of the significant drivers for digital therapeutic market. For instance, India was ranked 47th for smartphone penetration in 2013 by Google and 36th in 2015. Another significant factor advocating the popularity of digital therapeutics is the cost saving associated with it. Digital therapeutics allows mobile consultations and efficient management of chronic diseases. Chronic diseases are a major threat to the economy and their growth results in high healthcare costs. Statistics published by the CDC in 2012 state that the number of adults suffering from chronic health conditions in the U.S. accounts to about 50% of the total population, highlighting the increasing importance of chronic disease management.
Although the digital therapeutics is a growing market, it is still in its niche phase and is affected by the lack of effective monetization strategies faced by application developers. Currently, advertisements and paid content are the most prominent revenue generating models, but are falling short to meet the financial requirements.
The digital therapeutics market is fragmented in nature, with a large number of players, including tier 1 and mid-tier companies competing for market shares. The prominent players in the global digital therapeutics market include Noom (US), Livongo Health (US), Omada Health (US), WellDoc (US), Pear Therapeutics (US), Proteus Digital Health (US), Propeller Health (US), Akili Interactive Labs (US), Better Therapeutics (US), Happify (US), Kaia Health (Germany), Mango Health (US), Click Therapeutics (US), Canary Health (US), Wellthy Therapeutics (India), Cognoa (US), Ayogo Health (Canada), Mindstrong Health (US), 2Morrow (US), and Ginger (US).
Omada Health is a pioneer in the field of digital therapeutics. The company has attracted significant investments to enhance its solutions, particularly its digital prediabetes program ‘Prevent.’ In June 2019, the company secured USD 73 million from its investors for the development of digital care health programs focusing on preventable chronic conditions. To support its organic growth, the company focuses on R&D to continuously improve and upgrade its products. In this regard, in February 2016, Omada launched a new version of its Prevent program with additional features designed to meet the growing needs of its customers. In addition, the company is focusing on broadening its product offerings beyond diabetes—in January 2019, the company launched a mental health program, mHealth Platform, for anxiety and depression. The company is also working in partnership with many employers, payers, healthcare systems, and pharma companies.
Analyst Commentary
The growth of the digital therapeutics market is primarily driven by factors such as government initiatives for preventive healthcare, technological advancements in mobile healthcare, a significant increase in venture capital investments, and the benefits of digital therapeutics, such as the ability to induce behavioural change (an important challenge in healthcare), user-friendliness, patient convenience, and improved drug compliance. On the other hand, a lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, unstable payment models, and resistance from traditional healthcare providers are challenging the growth of this market to a certain extent.
Based on the application, the Rising healthcare costs, the growing prevalence of chronic diseases, and the ability of digital therapeutics to provide cost-effective solutions are some factors responsible for driving the market for treatment/care-related digital therapeutics applications.
Based on the type of buyer, the caregivers segment is expected to dominate the market and register the highest CAGR during the forecast period. The high growth of this segment is attributed to company initiatives for the development of products specifically for caregivers and the fact that digital therapeutics help caregivers in better managing their patients.
Based on the sales channel, the B2B segment accounted for the largest market share; it is also expected to grow at the highest CAGR of the digital therapeutics market. There is growing awareness among providers, payers, and employers about the benefits provided by digital therapeutics and the healthcare cost reductions achieved by their use. Additionally, there is a growing inclination of pharmaceutical companies to integrate digital therapeutics with their drug product to offer adherence services along with the product. These are some factors responsible for the high share of this market segment.
Segmentation
The global digital therapeutics market is segmented based on application, sales channel and region.Based on the application; the digital therapeutics market is segmented into preventive and treatment/care-related applications. Based on the sales channel, the digital therapeutics market is segmented into business-to-customer (B2C) and business-to-business (B2B).
Regional Analysis
The digital therapeutics market by region is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is a major regional segment in digital therapeutic market. Growing number of reforms to curb the increase in healthcare spending in the country coupled with drive to focus on a patient-centric healthcare approach is anticipated to be responsible for the same. Furthermore, North America is a major hub of a large number of digital therapy providers. The U.S. has been reported to spend USD 3 trillion a year on healthcare. In order to curb this expense, there is a dynamic shift in the U.S. healthcare landscape with focus directed toward preventive care, to promote overall patient wellness instead of medical treatment.
Asia Pacific is expected to register fastest growth rate, owing to two major factors: a highly dense population base that converts into a vast target base and rapid urbanization that includes rapidly changing technological landscape. In addition, constant reforms in countries to address lack of proper infrastructure and maintain sustainable growth through financial inclusion are expected to benefit the market.
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Engine Powered of Suppliers
3.7.2. Bargaining Engine Powered of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Digital Therapeutic Market
Chapter 5. Global Digital Therapeutic Market Overview, By Sales Channel, 2015 - 2027 (USD Billion)
5.1. Global Digital Therapeutic Market Share, By Sales Channel, 2015 - 2027 (USD Billion)
5.1.1. B2C
5.1.1.1. Market Size and Projections, 2015 - 2027 (USD Billion)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.2. B2B
5.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 6. Global Digital Therapeutic Market Overview, By Application, 2015 - 2027 (USD Billion)
6.1. Global Digital Therapeutic Market Share, By Application, 2015 - 2027 (USD Billion)
6.1.1. Preventive
6.1.1.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.2. Treatment/Care-Related
6.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 7. Global Digital Therapeutic Market Overview, By Geography, 2015 - 2027 (USD Billion)
7.1. Global Digital Therapeutic Market Share, By Geography, 2015 - 2027 (USD Billion)
7.1.1. Market Size and projections, by Countries, 2015 - 2027 (USD Billion)
7.1.2. Market Share and CAGR Comparison, by Countries, 2020 & 2027 (%)
Chapter 8. North America Digital Therapeutic Market Overview, By Countries, 2015 - 2027 (USD Billion)
8.1. North America Digital Therapeutic Market Overview, 2015 - 2027 (USD Billion)
8.1.1. Market size and projections, 2015 - 2027 (USD Billion)
8.1.2. North America Digital Therapeutic Market Overview, By Sales Channel, 2015 - 2027 (USD Billion)
8.1.3. North America Digital Therapeutic Market Overview, By Application, 2015 - 2027 (USD Billion)
8.1.4. North America Digital Therapeutic Market Overview, By Countries, 2015 - 2027 (USD Billion)
8.1.4.1. U.S. Digital Therapeutic Market Overview, 2015 - 2027 (USD Billion)
8.1.4.1.1. Market size and projections, 2015 - 2027 (USD Billion)
8.1.4.1.2. U.S. Digital Therapeutic Market Overview, By Sales Channel, 2015 - 2027 (USD Billion)
8.1.4.1.3. Other Segments
8.1.4.2. Canada Digital Therapeutic Market Overview, 2015 - 2027 (USD Billion)
8.1.4.2.1. Market size and projections, 2015 - 2027 (USD Billion)
8.1.4.2.2. Canada Digital Therapeutic Market Overview, By Sales Channel, 2015 - 2027 (USD Billion)
8.1.4.2.3. Other Segments
8.1.4.3. Mexico Digital Therapeutic Market Overview, 2015 - 2027 (USD Billion)
8.1.4.3.1. Market size and projections, 2015 - 2027 (USD Billion)
8.1.4.3.2. Mexico Digital Therapeutic Market Overview, By Sales Channel, 2015 - 2027 (USD Billion)
8.1.4.3.3. Other Segments
Chapter 9. Europe Digital Therapeutic Market Overview, By Countries, 2015 - 2027 (USD Billion)
9.1. Europe Digital Therapeutic Market Overview, 2015 - 2027 (USD Billion)
9.1.1. Market size and projections, 2015 - 2027 (USD Billion)
9.1.2. Europe Digital Therapeutic Market Overview, By Sales Channel, 2015 - 2027 (USD Billion)
9.1.3. Europe Digital Therapeutic Market Overview, By Application, 2015 - 2027 (USD Billion)
9.1.4. Europe Digital Therapeutic Market Overview, By Countries, 2015 - 2027 (USD Billion)
9.1.4.1. Germany
9.1.4.1.1. Market size and projections, 2015 - 2027 (USD Billion)
9.1.4.1.2. Germany Digital Therapeutic Market Overview, By Sales Channel, 2015 - 2027 (USD Billion)
9.1.4.1.3. Others Segments
9.1.4.2. France
9.1.4.2.1. Market size and projections, 2015 - 2027 (USD Billion)
9.1.4.2.2. France Digital Therapeutic Market Overview, By Sales Channel, 2015 - 2027 (USD Billion)
9.1.4.2.3. Others Segments
9.1.4.3. UK
9.1.4.3.1. Market size and projections, 2015 - 2027 (USD Billion)
9.1.4.3.2. UK Digital Therapeutic Market Overview, By Sales Channel, 2015 - 2027 (USD Billion)
9.1.4.3.3. Others Segments
9.1.4.4. Italy
9.1.4.4.1. Market size and projections, 2015 - 2027 (USD Billion)
9.1.4.4.2. Italy Digital Therapeutic Market Overview, By Sales Channel 2015 - 2027 (USD Billion)
9.1.4.4.3. Others Segments
9.1.4.5. Spain
9.1.4.5.1. Market size and projections, 2015 - 2027 (USD Billion)
9.1.4.5.2. Spain Digital Therapeutic Market Overview, By Sales Channel, 2015 - 2027 (USD Billion)
9.1.4.5.3. Others Segments
9.1.4.6. Rest of Europe
9.1.4.6.1. Market size and projections, 2015 – 2025
9.1.4.6.2. Rest of Europe Digital Therapeutic Market Overview, By Sales Channel, 2015 - 2027 (USD Billion)
9.1.4.6.3. Others Segments
Chapter 10. Asia Pacific Digital Therapeutic Market Overview, By Countries, 2015 - 2027 (USD Billion)
10.1. Asia Pacific Digital Therapeutic Market Overview, 2015 - 2027 (USD Billion)
10.1.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.2. Asia Pacific Digital Therapeutic Market Overview, By Sales Channel, 2015 - 2027 (USD Billion)
10.1.3. Asia Pacific Digital Therapeutic Market Overview, By Application, 2015 - 2027 (USD Billion)
10.1.4. Asia Pacific Digital Therapeutic Market Overview, By Countries, 2015 - 2027 (USD Billion)
10.1.4.1. India
10.1.4.1.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.4.1.2. India Digital Therapeutic Market Overview, By Sales Channel, 2015 - 2027 (USD Billion)
10.1.4.1.3. Other Segments
10.1.4.2. China
10.1.4.2.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.4.2.2. China Digital Therapeutic Market Overview, By Sales Channel, 2015 - 2027 (USD Billion)
10.1.4.2.3. Other Segments
10.1.4.3. Japan
10.1.4.3.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.4.3.2. Japan Digital Therapeutic Market Overview, By Sales Channel, 2015 - 2027 (USD Billion)
10.1.4.3.3. Other Segments
10.1.4.4. South Korea
10.1.4.4.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.4.4.2. South Korea Digital Therapeutic Market Overview, By Sales Channel, 2015 - 2027 (USD Billion)
10.1.4.4.3. Other Segments
10.1.4.5. Rest of Asia Pacific
10.1.4.5.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.4.5.2. Rest of Asia Pacific Digital Therapeutic Market Overview, By Sales Channel, 2015 - 2027 (USD Billion)
10.1.4.5.3. Other Segments
Chapter 11. Middle East & Africa Digital Therapeutic Market Overview, By Countries, 2015 - 2027 (USD Billion)
11.1. Middle East & Africa Digital Therapeutic Market Overview, 2015 - 2027 (USD Billion)
11.1.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.2. Middle East & Africa Digital Therapeutic Market Overview, By Sales Channel, 2015 - 2027 (USD Billion)
11.1.3. Middle East & Africa Digital Therapeutic Market Overview, By Application, 2015 - 2027 (USD Billion)
11.1.4. Middle East & Africa Digital Therapeutic Market Overview, By Countries, 2015 - 2027 (USD Billion)
11.1.4.1. GCC
11.1.4.1.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.4.1.2. GCC Digital Therapeutic Market Overview, By Sales Channel, 2015 - 2027 (USD Billion)
11.1.4.1.3. Other Segments
11.1.4.2. South Africa
11.1.4.2.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.4.2.2. South Africa Digital Therapeutic Market Overview, By Sales Channel, 2015 - 2027 (USD Billion)
11.1.4.2.3. Other Segments
11.1.4.3. Rest of Middle East & Africa
11.1.4.3.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.4.3.2. Rest of Middle East & Africa Digital Therapeutic Market Overview, By Sales Channel, 2015 - 2027 (USD Billion)
11.1.4.3.3. Other Segments
Chapter 12. South America Digital Therapeutic Market Overview, By Countries, 2015 - 2027 (USD Billion)
12.1. South America Digital Therapeutic Market Overview, 2015 - 2027 (USD Billion)
12.1.1. Market size and projections, 2015 - 2027 (USD Billion)
12.1.2. South America Digital Therapeutic Market Overview, By Sales Channel, 2015 - 2027 (USD Billion)
12.1.3. South America Digital Therapeutic Market Overview, By Application, 2015 - 2027 (USD Billion)
12.1.4. South America Digital Therapeutic Market Overview, By Countries, 2015- 2026 (USD Billion)
12.1.5. Brazil
12.1.5.1. Market size and projections, 2015 - 2027 (USD Billion)
12.1.5.2. Brazil Digital Therapeutic Market Overview, By Sales Channel, 2015 - 2027 (USD Billion)
12.1.5.3. Other Segments
12.1.6. Argentina
12.1.6.1. Market size and projections, 2015 - 2027 (USD Billion)
12.1.6.2. Argentina Digital Therapeutic Market Overview, By Sales Channel, 2015 - 2027 (USD Billion)
12.1.6.3. Other Segments
12.1.7. Rest of South America
12.1.7.1. Market size and projections, 2015 – 2027
12.1.7.2. Rest of South America Digital Therapeutic Market Overview, By Sales Channel, 2015 - 2027 (USD Billion)
12.1.7.3. Other Segments
Chapter 13. Competitive Landscape
13.1. Competitive environment, 2020
13.2. Strategic framework
13.2.1. Partnership/agreement
13.2.2. Expansion
13.2.3. Mergers & Acquisitions
13.2.4. New Distribution channel development
Chapter 14. Key Vendor Analysis
14.1. Noom.
14.1.1. Company overview
14.1.2. Financial performance
14.1.3. Distribution channel Benchmarking
14.1.4. Recent initiatives
14.1.5. SWOT analysis
14.2. Livongo Health
14.2.1. Company overview
14.2.2. Financial performance
14.2.3. Distribution channel Benchmarking
14.2.4. Recent initiatives
14.2.5. SWOT analysis
14.3. Omada Health.
14.4. WellDoc
14.5. Pear Therapeutics
14.6. Proteus Digital Health
14.7. PROPELLER HEALTH
14.8. Akili Interactive Labs
14.9. Better Therapeutics
14.10. Happify
Chapter 15. Digital Therapeutic Market Cost Analysis
15.1. Digital Therapeutic Market Key Raw Material Analysis
15.1.1. Key Raw Material
15.1.2. Price Trend of Key Raw Material
15.1.3. Key Suppliers of Raw Material
15.1.4. Market Concentration Rate of Raw Material
Chapter 16. Industrial Chain, Sourcing Strategy and Downstream Buyers
16.1. Digital Therapeutic Market Industrial Chain Analysis
16.2. Upstream Raw Material Sourcing
16.3. Raw Material Source of Digital Therapeutic Market Major Manufacturers in 2021
16.4. Downstream Buyers
Chapter 17. Marketing Strategy Analysis, Distributors/Traders
17.1. Marketing Channel
17.1.1. Direct Marketing
17.1.2. Indirect Marketing
17.1.3. Marketing Channel Development Trend
17.2. Market Positioning
17.2.1. Pricing Strategy
17.2.2. Brand Strategy
17.2.3. Target Treatment/care-related
17.3. Distributors/Traders List
Chapter 18. Market Effect Factors Analysis
18.1. Technology Progress/Risk
18.1.1. Substitutes Threat
18.1.2. Technology Progress in Related Distribution channel
18.2. Consumer Needs/Customer Preference Change
18.3. Economic/Political Environmental Change
Chapter 19. Future Outlook of the Market
Disclaimer
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Engine Powered of Suppliers
5. Engine Powered of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Digital Therapeutic Market share, By Sales Channel, 2020 & 2027 (%)
10. Global Digital Therapeutic Market share, by B2C, By Sales Channel, 2020 & 2027 (USD Billion)
11. Global Digital Therapeutic Market share, by B2B, By Sales Channel, 2020 & 2027 (USD Billion)
12. Global Digital Therapeutic Market share, By Application, 2020 & 2027 (%)
13. Global Digital Therapeutic Market share, by TREATMENT/CARE-RELATED, By Application, 2020 & 2027 (USD Billion)
14. Global Digital Therapeutic Market share, by Preventive, By Application, 2020 & 2027 (USD Billion)
15. Global Digital Therapeutic Market share, by Region, 2020 & 2027 (%)
16. Global Digital Therapeutic Market share, by region, 2020 - 2027(USD Billion)
17. North America Digital Therapeutic Market, 2020 - 2027(USD Billion)
18. North America Digital Therapeutic Market share, by Countries, 2020 & 2027 (%)
19. U.S. Digital Therapeutic Market, 2020 - 2027(USD Billion)
20. Canada Digital Therapeutic Market, 2020 - 2027(USD Billion)
21. Europe Digital Therapeutic Market, 2020 - 2027(USD Billion)
22. Europe Digital Therapeutic Market share, by Countries, 2020 & 2027 (%)
23. Spain Digital Therapeutic Market, 2020 - 2027(USD Billion)
24. UK Digital Therapeutic Market, 2020 - 2027(USD Billion)
25. Italy Digital Therapeutic Market, 2020 - 2027(USD Billion)
26. Germany Digital Therapeutic Market, 2020 - 2027(USD Billion)
27. France Digital Therapeutic Market, 2020 - 2027(USD Billion)
28. Rest of Europe Digital Therapeutic Market, 2020 - 2027(USD Billion)
29. Asia-Pacific Digital Therapeutic Market, 2020 - 2027(USD Billion)
30. Asia-Pacific Digital Therapeutic Market share, by Countries, 2020 & 2027 (%)
31. China Digital Therapeutic Market, 2020 - 2027(USD Billion)
32. India Digital Therapeutic Market, 2020 - 2027(USD Billion)
33. Australia Digital Therapeutic Market, 2020 - 2027(USD Billion)
34. Japan Digital Therapeutic Market, 2020 - 2027(USD Billion)
35. Rest of Asia-Pacific Digital Therapeutic Market, 2020 - 2027(USD Billion)
36. Middle East & Africa Digital Therapeutic Market, 2020 - 2027(USD Billion)
37. Middle East & Africa Digital Therapeutic Market share, by Countries, 2020 & 2027 (%)
38. GCC Digital Therapeutic Market, 2020 - 2027(USD Billion)
39. South Africa Digital Therapeutic Market, 2020 - 2027(USD Billion)
40. Rest Of Middle East & Africa Digital Therapeutic Market, 2020 - 2027(USD Billion)
41. South America Digital Therapeutic Market, 2020 - 2027(USD Billion)
42. Brazil Digital Therapeutic Market, 2020 - 2027(USD Billion)
43. Mexico Digital Therapeutic Market, 2020 - 2027(USD Billion)
44. Argentina Digital Therapeutic Market, 2020 - 2027(USD Billion)
45. Rest Of South America Digital Therapeutic Market, 2020 - 2027(USD Billion)
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Digital Therapeutic Market, 2020-2027 (USD Billion)
4. Digital Therapeutic requirement, by country, 2020-2027, (USD Billion)
5. North America Digital Therapeutic Market, By Sales Channel, 2020-2027 (USD Billion)
6. North America Digital Therapeutic Market, By Application, 2020-2027 (USD Billion)
7. North America Digital Therapeutic Market, By Product, 2020-2027 (USD Billion)
8. Europe Digital Therapeutic Market, By Sales Channel, 2020-2027 (USD Billion)
9. Europe Digital Therapeutic Market, By Application, 2020-2027 (USD Billion)
10. Europe Digital Therapeutic Market, By Product, 2020-2027 (USD Billion)
11. Asia Pacific Digital Therapeutic Market, By Sales Channel, 2020-2027 (USD Billion)
12. Asia Pacific Digital Therapeutic Market, By Application, 2020-2027 (USD Billion)
13. Asia Pacific Digital Therapeutic Market, By Product, 2020-2027 (USD Billion)
14. Middle East & Africa Digital Therapeutic Market, By Sales Channel, 2020-2027 (USD Billion)
15. Middle East & Africa Digital Therapeutic Market, By Application, 2020-2027 (USD Billion)
16. Middle East & Africa Digital Therapeutic Market, By Product, 2020-2027 (USD Billion)
17. South America Digital Therapeutic Market, By Sales Channel, 2020-2027 (USD Billion)
18. South America Digital Therapeutic Market, By Application, 2020-2027 (USD Billion)
19. South America Digital Therapeutic Market, By Product, 2020-2027 (USD Billion)
20. Global Digital Therapeutic Market, Company Market Share, 2020 & 2027(%)
21. Noom: Product Benchmarking
22. Noom: Financial Performance
23. Livongo Health : Product Benchmarking
24. Livongo Health : Financial Performance
25. Omada Health : Product Benchmarking
26. Omada Health : Financial Performance
27. Calbee, Inc. Product Benchmarking
28. Calbee, Inc. Financial Performance
29. Pear Therapeutics : Product Benchmarking
30. Pear Therapeutics : Financial Performance
31. Proteus Digital Health : Product Benchmarking
32. Proteus Digital Health : Financial Performance
33. Propeller Health : Product Benchmarking
34. Propeller Health : Financial Performance
35. Akili Interactive Labs : Product Benchmarking
36. Akili Interactive Labs : Financial Performance
37. Better Therapeutics : Product Benchmarking
38. Better Therapeutics : Financial Performance
39. Happify: Product Benchmarking
40. Happify: Financial Performance
The Leading Key Players in Digital Therapeutics Market
Noom (US)
Livongo Health (US)
Omada Health (US)
WellDoc (US)
Pear Therapeutics (US)
Proteus Digital Health (US)
Propeller Health (US)
Akili Interactive Labs (US)
Better Therapeutics (US)
Happify (US)
Kaia Health (Germany)
Mango Health (US)
Click Therapeutics (US)
Canary Health (US)
Wellthy Therapeutics (India)
Cognoa (US)
Ayogo Health (Canada)
Mindstrong Health (US)
2Morrow (US)
Ginger (US).
